Vikram Karnani is a seasoned executive who currently holds the position of President and Chief Executive Officer at Collegium Pharmaceutical Inc. With an extensive background in the pharmaceutical industry, Karnani has demonstrated a strong ability to lead and drive growth within organizations. Prior to joining Collegium, he served as President of the Established Pharma Business Unit at Amneal Pharmaceuticals, where he was instrumental in expanding the company's market presence and enhancing its product portfolio. At Collegium Pharmaceutical Inc., Karnani has been pivotal in steering the company towards its strategic goals, focusing on the development and commercialization of innovative treatments for pain management. Under his leadership, Collegium has successfully navigated the complex landscape of pharmaceutical regulations and market dynamics, achieving significant milestones in product development and market expansion. Karnani's strategic vision and operational expertise have been crucial in positioning Collegium as a leader in the pain management sector. Karnani's achievements extend beyond his current role at Collegium. He has a proven track record of building high-performing teams and fostering a culture of innovation and excellence. His educational background includes a Bachelor of Science in Chemical Engineering from the University of Pennsylvania and an MBA from The Wharton School, which have equipped him with a solid foundation in both technical and business acumen. Karnani's leadership at Collegium continues to drive the company forward, ensuring it remains at the forefront of delivering effective and safe pain management solutions to patients.